Metastatic Hormone Refractory Prostate Cancer Terminated Phase 4 Trials for Leuprolide (DB00007)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01933022A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the DiseaseOther